Fan Yong - Net Worth and Insider Trading
Fan Yong Net Worth
The estimated net worth of Fan Yong is at least $0 dollars as of 2024-06-22. Fan Yong is the Executives of Changzhou Qianhong Biopharma Co Ltd and owns about 0 shares of Changzhou Qianhong Biopharma Co Ltd (SZSE:002550) stock worth over $0. Details can be seen in Fan Yong's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Fan Yong has not made any transactions after 2017-12-21 and currently still holds the listed stock(s).
Transaction Summary of Fan Yong
Fan Yong Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Fan Yong owns 1 companies in total, including Changzhou Qianhong Biopharma Co Ltd (SZSE:002550) .
Click here to see the complete history of Fan Yong’s form 4 insider trades.
Insider Ownership Summary of Fan Yong
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| SZSE:002550 | Changzhou Qianhong Biopharma Co Ltd | 2017-12-21 | Executives |
Fan Yong Latest Holdings Summary
Fan Yong currently owns a total of 1 stock. Fan Yong owns 0 shares of Changzhou Qianhong Biopharma Co Ltd (SZSE:002550) as of December 21, 2017, with a value of $0.
Latest Holdings of Fan Yong
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| SZSE:002550 | Changzhou Qianhong Biopharma Co Ltd | 2017-12-21 | 0 | 5.50 | 0 |
Holding Weightings of Fan Yong
Fan Yong Form 4 Trading Tracker
According to the SEC Form 4 filings, Fan Yong has made a total of 0 transactions in Changzhou Qianhong Biopharma Co Ltd (SZSE:002550) over the past 5 years. The most-recent trade in Changzhou Qianhong Biopharma Co Ltd is the acquisition of 440,000 shares on December 21, 2017, which cost Fan Yong around $2 Million.
Insider Trading History of Fan Yong
- 1
Fan Yong Trading Performance
GuruFocus tracks the stock performance after each of Fan Yong's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Fan Yong is 10.11%. GuruFocus also compares Fan Yong's trading performance to market benchmark return within the same time period. The performance of stocks bought by Fan Yong within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Fan Yong's insider trading performs compared to the benchmark.
Performance of Fan Yong
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -0.37 | | | | | |
| Relative Return to S&P 500(%) | -5.05 | | | | | |
Fan Yong Ownership Network
Fan Yong Owned Company Details
What does Changzhou Qianhong Biopharma Co Ltd do?
Who are the key executives at Changzhou Qianhong Biopharma Co Ltd?
Fan Yong is the Executives of Changzhou Qianhong Biopharma Co Ltd. Other key executives at Changzhou Qianhong Biopharma Co Ltd include Directors & executives Wang Ke , Supervisors Jiang Wen Qun , and Executives Zou Shao Bo .
Changzhou Qianhong Biopharma Co Ltd (SZSE:002550) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Changzhou Qianhong Biopharma Co Ltd (SZSE:002550) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Changzhou Qianhong Biopharma Co Ltd (SZSE:002550) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Changzhou Qianhong Biopharma Co Ltd (SZSE:002550)'s detailed insider trading history can be found in Insider Trading Tracker table.
Changzhou Qianhong Biopharma Co Ltd Insider Transactions
Fan Yong Mailing Address
Above is the net worth, insider trading, and ownership report for Fan Yong. Currently GuruFocus does not have mailing address information for Fan Yong.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
